The Plaque Modification Device market is a subset of the Cardiovascular Devices market. It includes devices used to treat atherosclerosis, a condition in which plaque builds up in the arteries. These devices are used to reduce the risk of stroke, heart attack, and other cardiovascular diseases. Plaque Modification Devices can be divided into two categories: mechanical and pharmacological. Mechanical devices include atherectomy, angioplasty, and stenting. Pharmacological devices include drug-eluting stents and drug-coated balloons. The Plaque Modification Device market is expected to grow due to increasing prevalence of cardiovascular diseases, technological advancements, and rising demand for minimally invasive treatments. Some companies in the Plaque Modification Device market include Abbott, Boston Scientific, Medtronic, Terumo, and Biosensors International. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
